There is a class of drugs that lead to weight loss, glucagon-like peptide 1 (GLP-1) agonists and the total GLP-1 market (includes peptides, orals and injectables), is estimated to be worth ~$37 billion in 2023, with projected growth to $138 billion by 2031
Association of GLP-1 secretion with anti-hyperlipidemic effect of ginsenosides in high-fat diet fed rats
The global market is projected to register a CAGR of 21.39% during 20262034
Mendis, B., Simpson, E., MacDonald, I
Ordering, Delivery & Returns: UK Research Buyers All orders ship free within the UK via Royal Mail tracked, in plain unbranded outer packaging, with typical delivery in 13 working days
Le label suisse Carnipure garantit une L-Carnitine teste, confirme et hautement biodisponible , contrairement dautres formes moins concentres ou non certifies